Article info

Download PDFPDF
Extended report
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)

Authors

  1. Correspondence to Professor P Emery, Division of Rheumatic and Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit, LTHT, Leeds, UK; p.emery{at}leeds.ac.uk
View Full Text

Citation

Nam JL, Villeneuve E, Hensor EMA, et al
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)

Publication history

  • Received February 8, 2013
  • Revised June 3, 2013
  • Accepted July 9, 2013
  • First published August 2, 2013.
Online issue publication 
December 04, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.